Government Expert Panel Approves AstraZeneca / Oxford Covid-19 Vaccine for Emergency Use
India’s drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and the University of Oxford for emergency use, two sources with knowledge of the matter told Reuters.
The approval paves the way for its implementation in the second most affected country in the world.
A representative from India’s Central Drug Control Organization (CDSCO), whose experts are meeting for the second time this week and are also considering two other vaccines, declined to comment.
Great Britain and Argentina have already authorized the vaccine for urgent public use.
India wants to start giving injections soon.
It is also considering emergency use authorization applications for vaccines made by Pfizer Inc with BioNTech of Germany and Bharat Biotech of India.
At more than 10 million, India has reported the second highest number of coronavirus cases after the United States, although its infection rate has dropped significantly from a peak in mid-September.